Skip to main content

Table 2 Results of calibration process for main model estimations

From: Health economic analysis of human papillomavirus vaccines in women of Chile: perspective of the health care payer using a Markov model

  Model estimated Reported Reference
Prevalence of oncogenic HPV infections 9.7% 9.1% (15–69 years) [10, 36]
Prevalence of low risk HPV infections 3.1% 3.7% (15–69 years) [36]
Incident cases of genital warts 4813 4685 [35]
Incident cases of cervical cancer 1370 1331 [35]
Incident cases of deaths associated with cervical cancer 722 759 [35]
  1. Note: HPV: human papillomavirus.
\